Welcome to our dedicated page for Centene Del SEC filings (Ticker: CNC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to Centene Corporation (NYSE: CNC) SEC filings, offering insight into the company’s regulatory disclosures, financial communications, and governance updates. As a healthcare enterprise focused on government-sponsored and commercial healthcare programs, Centene uses filings such as Form 8-K to inform investors about material events, earnings information, and board changes.
Recent 8-K filings describe Centene’s participation in healthcare investor conferences, where management discusses the company’s financial outlook and the use of non-GAAP financial measures like adjusted diluted earnings per share. Other 8-Ks report quarterly financial results, the withdrawal or update of earnings guidance, and the resignation of directors along with resulting changes in the size of the board. These documents help investors understand how Centene evaluates its performance, plans operations, and manages corporate governance.
Through this filings page, users can review Centene’s current and historical submissions to the U.S. Securities and Exchange Commission, including annual and quarterly reports when available, as well as event-driven filings. Real-time updates from EDGAR are combined with AI-powered summaries that explain the key points of complex documents, helping readers interpret financial metrics, non-GAAP reconciliations, and narrative disclosures without wading through every page.
In addition to financial information, Centene’s filings may address topics such as regulatory considerations, risk factors related to government healthcare programs, and the company’s approach to non-GAAP reporting. For investors tracking CNC, this page serves as a central location to monitor new filings, understand the context of earnings announcements, and follow changes in leadership or guidance as they are formally reported to the SEC.
Centene Corp reported a Schedule 13G filing: Vanguard Capital Management reports beneficial ownership of 35,946,964 shares of Centene common stock, representing 7.30% of the class. The filing states Vanguard has sole dispositive power over the 35,946,964 shares and sole voting power for 4,712,899 shares. The filing lists Vanguard Capital Management's address as 100 Vanguard Blvd., Malvern, PA and is signed by Ashley Grim as Head of Global Fund Administration.
Centene Corporation reported strong first quarter 2026 results, with total revenues of $49.9 billion and premium and service revenues of $44.7 billion, up 5% from the prior year period. GAAP diluted EPS rose to $3.11 from $2.63, while adjusted diluted EPS increased to $3.37 from $2.90, reflecting better-than-expected profitability.
The consolidated health benefits ratio improved slightly to 87.3%, including Medicaid at 93.1%, Medicare at 84.9% and Commercial at 75.3%. Cash flow from operations was $4.4 billion, supported by strong earnings and a partial sale of CMS Part D receivables.
Centene reduced total debt by $1.0 billion during the quarter, ending with $16.4 billion of debt and a debt-to-capitalization ratio of 43.2%. The company raised 2026 guidance, increasing premium and service revenue expectations to $171.0–$175.0 billion and setting floors for GAAP EPS above $2.37 and adjusted EPS above $3.40.
Centene Corporation’s Chief People Officer Tanya M. McNally had 964 shares of common stock withheld on April 15, 2026 to cover tax obligations when previously granted restricted stock units vested at a price of $37.26 per share. After this tax-withholding disposition, she holds 127,258 shares directly, including 112,054 restricted and performance stock units that remain subject to vesting requirements.
Centene Corp director Kenneth Tanji reported receiving a grant of 1,179 shares of Common Stock as a compensation-related award. The shares were acquired at no purchase price, increasing his direct holdings to 7,917 shares. Ownership includes 3,579 restricted stock units that are subject to vesting requirements.
Samuels Theodore R. II reported acquisition or exercise transactions in this Form 4 filing.
Centene Corp director Theodore R. Samuels II received a grant of 943 shares of Common Stock as a stock award. The award was recorded at a price of $0.00 per share and increased his directly held stake to 20,755.979 shares.
He also has indirect ownership of 32,000 shares through a revocable family trust where he serves as co-trustee. Ownership further includes 3,579 shares of restricted stock units that are subject to vesting requirements.
EPPINGER FREDERICK H reported acquisition or exercise transactions in this Form 4 filing.
Centene Corporation director Frederick H. Eppinger reported receiving a grant of 1,690 shares of common stock, recorded at $0.00 per share as a compensation-related award, not an open-market purchase. Following this grant, he directly holds 362,050.658 common shares.
A footnote states that this ownership figure also includes 5,965 shares of restricted stock units that are subject to vesting requirements, meaning those shares will be delivered only if the vesting conditions are met.
COUGHLIN CHRISTOPHER J reported acquisition or exercise transactions in this Form 4 filing.
Centene Corp director Christopher J. Coughlin received an equity award of 1,140 shares of common stock on March 31, 2026. The shares were granted at no cash cost as a stock-based compensation award, increasing his directly held common stock to 14,156.926 shares.
He also has indirect ownership of 30,054 shares held by a grantor retained annuity trust for the benefit of Mr. Coughlin and his adult children, where he serves as sole trustee. His direct ownership includes 3,579 restricted stock units that remain subject to vesting requirements.
Centene Corp executive Theodore J. Pienkos, Corporate Controller and Chief Accounting Officer, filed an initial ownership report showing 29,843.4930 shares of common stock held directly. This total includes 16,140 restricted stock units that vest in scheduled installments between September 15, 2026 and March 15, 2027.
The ownership also includes 1,381 performance stock units reported at target level, granted on March 15, 2024. The number of these performance units that will actually vest on March 15, 2027 can range from 0% to 200% of the target amount, depending on achievement of performance conditions.
Centene Corp executive Theodore J. Pienkos, Corporate Controller and Chief Accounting Officer, filed an initial ownership report showing 29,843.4930 shares of common stock held directly. This total includes 16,140 restricted stock units that vest in scheduled installments between September 15, 2026 and March 15, 2027.
The ownership also includes 1,381 performance stock units reported at target level, granted on March 15, 2024. The number of these performance units that will actually vest on March 15, 2027 can range from 0% to 200% of the target amount, depending on achievement of performance conditions.
Centene Corp executive Theodore J. Pienkos, Corporate Controller and Chief Accounting Officer, filed an initial ownership report showing 29,843.4930 shares of common stock held directly. This total includes 16,140 restricted stock units that vest in scheduled installments between September 15, 2026 and March 15, 2027.
The ownership also includes 1,381 performance stock units reported at target level, granted on March 15, 2024. The number of these performance units that will actually vest on March 15, 2027 can range from 0% to 200% of the target amount, depending on achievement of performance conditions.
Centene Corp: The Vanguard Group amends Schedule 13G to report zero beneficial ownership. The filing (Amendment No. 14) states amount beneficially owned: 0 and percent of class: 0% after an internal realignment; subsidiaries and business divisions will report separately in reliance on SEC Release No. 34-39538 (January 12, 1998).